LAVA Therapeutics NV — Investor Relations & Filings
LAVA Therapeutics NV is a clinical-stage immuno-oncology company that develops cancer therapies through its proprietary Gammabody® platform. This platform generates bispecific antibodies designed to engage and activate Vγ9Vδ2 (Vgamma9 Vdelta2) T cells, a unique and abundant subset of immune effector cells. The therapeutic approach aims to direct these T cells to tumors, leading to the selective killing of cancer cells and the stimulation of a broader, durable anti-tumor immune response. The company's focus is on creating treatments that complement natural tumor recognition and have the potential to enhance patient survival across various malignancies.
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 13363908 | 15-12G | 2025-12-16 | English | ||
| 13363910 | Regulatory Filings 2025 | 2025-11-21 | English | ||
| 13363909 | S-8 POS | 2025-11-21 | English | ||
| 13363911 | S-8 POS | 2025-11-21 | English | ||
| 13363913 | SC 14D9/A | 2025-11-21 | English | ||
| 13363917 | FORM 8-K | 2025-11-21 | English | ||
| 13363912 | Director's Dealing 2025 | 2025-11-17 | English | ||
| 13363914 | Director's Dealing 2025 | 2025-11-17 | English | ||
| 13363915 | Director's Dealing 2025 | 2025-11-17 | English | ||
| 13363916 | Director's Dealing 2025 | 2025-11-17 | English | ||
| 13363918 | Director's Dealing 2025 | 2025-11-17 | English | ||
| 13363921 | Director's Dealing 2025 | 2025-11-17 | English | ||
| 13363919 | Director's Dealing 2025 | 2025-11-17 | English | ||
| 13363920 | Director's Dealing 2025 | 2025-11-17 | English | ||
| 13363924 | Director's Dealing 2025 | 2025-11-17 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for LAVA Therapeutics NV, but not for this combination of statement and period. Try a different combination.
| Line item | ! |
|---|---|
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
LAVA Therapeutics NV via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34663/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34663 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34663 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34663 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34663}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for LAVA Therapeutics NV (id: 34663)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.